$AUPH
Aurinia Pharmaceuticals Inc.

2022 Q3 Form 10-Q Financial Statement

#000162828022020820 Filed on August 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $55.78M $28.19M $21.63M
YoY Change 280.3% 325.85% 2265.97%
Cost Of Revenue $2.447M $1.599M $256.0K
YoY Change 863.39% 419.16% 433.33%
Gross Profit $53.33M $26.59M $21.37M
YoY Change 270.03% 321.29% 2367.55%
Gross Profit Margin 95.61% 94.33% 98.82%
Selling, General & Admin $52.17M $51.53M $45.20M
YoY Change 18.22% 17.69% 15.06%
% of Gross Profit 97.82% 193.79% 211.51%
Research & Development $10.97M $11.53M $12.62M
YoY Change -45.32% 14.21% 28.34%
% of Gross Profit 20.57% 43.34% 59.06%
Depreciation & Amortization $809.0K $991.0K $687.0K
YoY Change 304.5% 395.5% -0.15%
% of Gross Profit 1.52% 3.73% 3.21%
Operating Expenses $10.97M $11.53M $12.62M
YoY Change -83.12% -78.56% -75.47%
Operating Profit -$9.499M -$35.99M -$37.88M
YoY Change -81.14% -23.65% -25.05%
Interest Expense $1.464M $483.0K $262.0K
YoY Change 1281.13% 240.14% 52.33%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$8.035M -$35.51M -$37.62M
YoY Change -84.01% -24.44% -25.31%
Income Tax $1.000M $9.000K $10.00K
% Of Pretax Income
Net Earnings -$8.989M -$35.52M -$37.63M
YoY Change -82.11% -24.45% -25.31%
Net Earnings / Revenue -16.12% -125.98% -174.01%
Basic Earnings Per Share -$0.06 -$0.25 -$0.27
Diluted Earnings Per Share -$0.06 -$0.25 -$0.27
COMMON SHARES
Basic Shares Outstanding 141.9M shares 141.7M shares 141.7M shares
Diluted Shares Outstanding 141.9M shares 141.7M shares 141.7M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $376.6M $391.7M $418.8M
YoY Change 31.51% 22.9% 20.24%
Cash & Equivalents $85.34M $151.4M $131.6M
Short-Term Investments $290.6M $240.1M $286.2M
Other Short-Term Assets $3.808M $1.088M $3.966M
YoY Change 423.08% 22.8% 236.1%
Inventory $25.32M $25.86M $26.27M
Prepaid Expenses $12.16M $17.42M $12.20M
Receivables $41.77M $18.17M $20.40M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $459.7M $453.2M $477.6M
YoY Change 39.63% 29.6% 28.31%
LONG-TERM ASSETS
Property, Plant & Equipment $3.758M $4.183M $4.332M
YoY Change -17.42% -13.09% -8.95%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.05M $12.36M $11.84M
YoY Change 10.23% 4.21% -0.15%
Total Long-Term Assets $28.59M $28.96M $29.28M
YoY Change -7.31% -20.84% -34.68%
TOTAL ASSETS
Total Short-Term Assets $459.7M $453.2M $477.6M
Total Long-Term Assets $28.59M $28.96M $29.28M
Total Assets $488.3M $482.1M $506.9M
YoY Change 35.61% 24.82% 21.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $821.0K $3.267M
YoY Change -67.61% 49.73%
Accrued Expenses $40.98M $32.51M $30.07M
YoY Change 47.3% 33.2% 81.28%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $41.77M $34.63M $33.84M
YoY Change 11.26% 18.12% 59.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $15.80M $16.30M $17.40M
YoY Change -4.82% -3.55% -2.79%
Total Long-Term Liabilities $15.80M $16.30M $17.40M
YoY Change -4.82% -3.55% -2.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $41.77M $34.63M $33.84M
Total Long-Term Liabilities $15.80M $16.30M $17.40M
Total Liabilities $64.87M $58.38M $58.78M
YoY Change 4.8% 8.09% 25.46%
SHAREHOLDERS EQUITY
Retained Earnings -$838.3M -$829.3M -$793.8M
YoY Change 15.97% 23.3% 26.89%
Common Stock $79.19M $74.00M $64.69M
YoY Change 45.01% 45.04% 47.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $423.4M $423.8M $448.1M
YoY Change
Total Liabilities & Shareholders Equity $488.3M $482.1M $506.9M
YoY Change 35.61% 24.82% 21.54%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$8.989M -$35.52M -$37.63M
YoY Change -82.11% -24.45% -25.31%
Depreciation, Depletion And Amortization $809.0K $991.0K $687.0K
YoY Change 304.5% 395.5% -0.15%
Cash From Operating Activities -$15.36M -$27.87M -$46.75M
YoY Change -61.83% -26.61% -12.69%
INVESTING ACTIVITIES
Capital Expenditures -$40.00K -$39.00K -$79.00K
YoY Change -36.51% -82.43% -93.31%
Acquisitions
YoY Change
Other Investing Activities -$50.18M $45.66M -$52.94M
YoY Change 53.25% 2313.32% -19.87%
Cash From Investing Activities -$50.22M $45.62M -$53.02M
YoY Change 53.08% 2631.8% -21.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 1.340M $405.0K
YoY Change -100.0% 4.77% -91.95%
NET CHANGE
Cash From Operating Activities -15.36M -27.87M -$46.75M
Cash From Investing Activities -50.22M 45.62M -$53.02M
Cash From Financing Activities 0.000 1.340M $405.0K
Net Change In Cash -65.58M 19.09M -$99.36M
YoY Change 2.51% -154.5% -14.17%
FREE CASH FLOW
Cash From Operating Activities -$15.36M -$27.87M -$46.75M
Capital Expenditures -$40.00K -$39.00K -$79.00K
Free Cash Flow -$15.32M -$27.83M -$46.67M
YoY Change -61.87% -26.29% -10.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001600620
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei City Area Code
CityAreaCode
(250)
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36421
dei Entity Registrant Name
EntityRegistrantName
Aurinia Pharmaceuticals Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Z4
dei Entity Address Address Line1
EntityAddressAddressLine1
#1203-4464 Markham Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Victoria
dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V8Z 7X8
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1231763
dei Local Phone Number
LocalPhoneNumber
708-4272
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
141892181 shares
dei Security12b Title
Security12bTitle
Common shares, no par value
dei Trading Symbol
TradingSymbol
AUPH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
151632000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
231900000 usd
CY2022Q2 us-gaap Debt Securities Current
DebtSecuritiesCurrent
240104000 usd
CY2021Q4 us-gaap Debt Securities Current
DebtSecuritiesCurrent
234178000 usd
CY2022Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
18173000 usd
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
15414000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
25863000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
19326000 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
17421000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12506000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
453193000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
513324000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12355000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11838000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4183000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4418000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7338000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8404000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5079000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5383000 usd
CY2022Q2 us-gaap Assets
Assets
482148000 usd
CY2021Q4 us-gaap Assets
Assets
543367000 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
32380000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
34947000 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1293000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4640000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
953000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1059000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
34626000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
40646000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16323000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15950000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7431000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7680000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
58380000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
64276000 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
141892000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
141892000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
141600000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
141600000 shares
CY2022Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1180884000 usd
CY2021Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1177051000 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
74004000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
59014000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1853000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-852000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-829267000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-756122000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
423768000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
479091000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
482148000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
543367000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28191000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6620000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49816000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7534000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
1599000 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
308000 usd
us-gaap Cost Of Revenue
CostOfRevenue
1855000 usd
us-gaap Cost Of Revenue
CostOfRevenue
356000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51532000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44322000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
96729000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
84127000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11525000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10091000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24145000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19924000 usd
CY2022Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
476000 usd
CY2021Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
967000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-958000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-804000 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
64180000 usd
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
53754000 usd
us-gaap Costs And Expenses
CostsAndExpenses
123687000 usd
us-gaap Costs And Expenses
CostsAndExpenses
105211000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-35989000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-47134000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-73871000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-97677000 usd
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
483000 usd
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
142000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
745000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
314000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35506000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-46992000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-73126000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-97363000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000 usd
us-gaap Net Income Loss
NetIncomeLoss
-73145000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-35515000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-47010000 usd
us-gaap Net Income Loss
NetIncomeLoss
-97389000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0 usd
CY2022Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-235000 usd
CY2021Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
7000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1001000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
13000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35750000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-47003000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-74146000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-97376000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.76
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
141726000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
141726000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
128222000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
128222000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
141734000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
141734000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127814000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
127814000 shares
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17078000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
448123000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
117000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1223000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10055000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-235000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-35515000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
423768000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
370228000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1279000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7753000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-47010000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
332257000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
479091000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
522000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1223000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1001000 usd
us-gaap Net Income Loss
NetIncomeLoss
-73145000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
423768000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
407750000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6278000 usd
us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
31000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15574000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13000 usd
us-gaap Net Income Loss
NetIncomeLoss
-97389000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
332257000 usd
us-gaap Net Income Loss
NetIncomeLoss
-73145000 usd
us-gaap Net Income Loss
NetIncomeLoss
-97389000 usd
us-gaap Depreciation
Depreciation
1678000 usd
us-gaap Depreciation
Depreciation
1264000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
17078000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
15574000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2511000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2904000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
2758000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
4418000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7953000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3449000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
4914000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1987000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
517000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-229000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6242000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1031000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-355000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
529000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-74617000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-91520000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
232955000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
216987000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
225677000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
164651000 usd
us-gaap Payments To Acquire Lease Receivables
PaymentsToAcquireLeaseReceivables
0 usd
us-gaap Payments To Acquire Lease Receivables
PaymentsToAcquireLeaseReceivables
11838000 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
118000 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
364000 usd
us-gaap Payments For Software
PaymentsForSoftware
0 usd
us-gaap Payments For Software
PaymentsForSoftware
1039000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7396000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-65577000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1745000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6278000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
30000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1745000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6308000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-80268000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-150789000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
231900000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
272350000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
151632000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121561000 usd
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
528000 usd
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
376000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
779000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
236000 usd
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
572000 usd
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
128000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
419000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
151408000 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121561000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
224000 usd
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
151632000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121561000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2022Q2 auph Cash Cash Equivalents And Debt Securities Current
CashCashEquivalentsAndDebtSecuritiesCurrent
391700000 usd
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
200000 usd
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
300000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Major Customers: The Company currently has two main customers for U.S. commercial sales of LUPKYNIS and one customer for sales of voclosporin in the European Union, Japan, as well as the United Kingdom, Russia, Switzerland, Norway, Belarus, Iceland, Liechtenstein and Ukraine. Revenues from the two main customers in the U.S. accounted for approximately 54% and 45% respectively of the Company's total revenues for the three and six months ended June 30, 2022. In late March 2022, we provided a nominal additional discount to both of our two main customers, applicable for the remainder of the 2022 calendar year, in connection with holding additional amounts of LUPKYNIS on hand due to supply chain concerns. The Company monitors economic conditions, the creditworthiness of customers and government regulations and funding, both domestically and abroad. The Company regularly communicates with its customers regarding the status of receivable balances. Global economic conditions and customer specific factors may require the Company to periodically re-evaluate the collectability of its receivables and based on this evaluation the Company could potentially incur credit losses.
CY2022Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
18200000 usd
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
15400000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
391736000 usd
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
466078000 usd
CY2022Q2 auph Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Short Term Investments
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndShortTermInvestments
391700000 usd
CY2021Q4 auph Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Short Term Investments
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndShortTermInvestments
466100000 usd
CY2022Q2 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Current
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent
3400000 usd
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
388400000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
446900000 usd
CY2021Q4 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Current
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent
19200000 usd
CY2022Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
389422000 usd
CY2022Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
0 usd
CY2022Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
1048000 usd
CY2022Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
388374000 usd
CY2022Q2 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Current
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent
3362000 usd
CY2022Q2 auph Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Short Term Investments
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndShortTermInvestments
391736000 usd
CY2021Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
446897000 usd
CY2021Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
0 usd
CY2021Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
47000 usd
CY2021Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
446850000 usd
CY2021Q4 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Current
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent
19228000 usd
CY2021Q4 auph Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Short Term Investments
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndShortTermInvestments
466078000 usd
CY2022Q2 us-gaap Interest Receivable
InterestReceivable
900000 usd
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
100000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
235000 usd
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
1000000 usd
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1400000 usd
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2217000 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2217000 usd
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
19418000 usd
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
12566000 usd
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4228000 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4543000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
25863000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
19326000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12111000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7338000 usd
CY2022Q2 auph Prepaid Assets Current
PrepaidAssetsCurrent
8320000 usd
CY2021Q4 auph Prepaid Assets Current
PrepaidAssetsCurrent
5316000 usd
CY2022Q2 us-gaap Deposits Assets Current
DepositsAssetsCurrent
4109000 usd
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
4762000 usd
CY2022Q2 us-gaap Prepaid Insurance
PrepaidInsurance
3904000 usd
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1632000 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1088000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
796000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17421000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12506000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19449000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19470000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11066000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8404000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 usd
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1100000 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5344000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5254000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1161000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
836000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4183000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4418000 usd
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
300000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
300000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
500000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
500000 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y1M6D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0522
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
566000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1061000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1085000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1110000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1135000 usd
CY2022Q2 auph Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
5638000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10595000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2211000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
8384000 usd
CY2021Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
21000000 chf
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
11800000 usd
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
10500000 chf
CY2022Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
74000000 usd
CY2022Q2 auph Lessee Operating Lease Lease Not Yet Commenced Payments Prior To Commencement Of Lease
LesseeOperatingLeaseLeaseNotYetCommencedPaymentsPriorToCommencementOfLease
885000 usd
CY2022Q2 auph Lessee Operating Lease Lease Not Yet Commenced Liability To Be Paid
LesseeOperatingLeaseLeaseNotYetCommencedLiabilityToBePaid
119000 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12449000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18278000 usd
CY2022Q2 auph Commercial Related Accruals Current
CommercialRelatedAccrualsCurrent
8880000 usd
CY2021Q4 auph Commercial Related Accruals Current
CommercialRelatedAccrualsCurrent
5916000 usd
CY2022Q2 auph Accrued Research Current
AccruedResearchCurrent
5731000 usd
CY2021Q4 auph Accrued Research Current
AccruedResearchCurrent
6412000 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4499000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3527000 usd
CY2022Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
821000 usd
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
814000 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
32380000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
34947000 usd
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
128222000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
141734000 shares
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16300000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-35515000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-47010000 usd
us-gaap Net Income Loss
NetIncomeLoss
-73145000 usd
us-gaap Net Income Loss
NetIncomeLoss
-97389000 usd
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
141726000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
141726000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
128222000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
141734000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127814000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
127814000 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.76
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16363000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15792000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.70
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.66
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0183
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0035
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
auph Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.117
auph Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.088
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
0.000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
0.000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.59
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12074000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.84
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3061000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.96
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
77000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.75
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
703000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
15.73
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14355000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.54
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10055000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7753000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17078000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15574000 usd
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
39200000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y4M24D
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000 usd

Files In Submission

Name View Source Status
0001628280-22-020820-index-headers.html Edgar Link pending
0001628280-22-020820-index.html Edgar Link pending
0001628280-22-020820.txt Edgar Link pending
0001628280-22-020820-xbrl.zip Edgar Link pending
auph-20220630.htm Edgar Link pending
auph-20220630.xsd Edgar Link pending
auph-20220630_cal.xml Edgar Link unprocessable
auph-20220630_def.xml Edgar Link unprocessable
auph-20220630_htm.xml Edgar Link completed
auph-20220630_lab.xml Edgar Link unprocessable
auph-20220630_pre.xml Edgar Link unprocessable
auph-2022q2exx311.htm Edgar Link pending
auph-2022q2exx312.htm Edgar Link pending
auph-2022q2exx321.htm Edgar Link pending
auph-2022q2exx322.htm Edgar Link pending
exhibit1022employeeagreeme.htm Edgar Link pending
exhibit1023employmentagree.htm Edgar Link pending
exhibit1046commercialsuppl.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending